—
C+
C+ The full Closelooknet — membership. Open the C+ overview

TG Therapeutics Inc (TGTX) — Technical state

As of 2026-10-30 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 56 out of 100 (momentum 92 · quality 69 · valuation 24), as of 2026-11-01.
  • Signal: Uptrend stack intact — Trades +10.6% vs the 50-day and +39.7% vs the 200-day average, 0.9% below the 52-week high and +128.6% off the 52-week low. Computed from daily closes. (as of 2026-10-30)
  • Trend: TG Therapeutics Inc trades 10.6% above its 50-day and 39.7% above its 200-day moving average. (as of 2026-10-30)

TG Therapeutics is a commercial-stage biopharmaceutical company that develops treatments for diseases driven by B-cells, a type of immune cell. Its approved product, an antibody therapy for relapsing forms of multiple sclerosis, is sold in the United States and other markets.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the TGTX overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +10.6% vs the 50-day and +39.7% vs the 200-day average, 0.9% below the 52-week high and +128.6% off the 52-week low. Computed from daily closes.

Ranked #3 on today’s Directional Flow — near their highs list (scan of 2026-11-02).

The moving-average stack

Continue: the TGTX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-30

Quick answers

What is the current Closelooknet signal on TGTX?

Uptrend stack intact — Trades +10.6% vs the 50-day and +39.7% vs the 200-day average, 0.9% below the 52-week high and +128.6% off the 52-week low. Computed from daily closes. As of 2026-10-30; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is TGTX above its 50-day and 200-day moving averages?

As of 2026-10-30, TG Therapeutics Inc trades +10.6% above its 50-day and +39.7% above its 200-day average, with the 20-day +11.4% away.

How far is TGTX from its 52-week high?

0.9% below the 52-week high and 128.6% above the 52-week low, as of 2026-10-30.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.